(NYSE: CHE) Chemed's forecast annual revenue growth rate of 5.95% is forecast to beat the US Medical Care Facilities industry's average forecast revenue growth rate of 4.11%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 16.2%.
Chemed's revenue in 2026 is $2,595,001,000.On average, 5 Wall Street analysts forecast CHE's revenue for 2026 to be $35,916,252,828, with the lowest CHE revenue forecast at $34,792,236,182, and the highest CHE revenue forecast at $37,380,088,460. On average, 5 Wall Street analysts forecast CHE's revenue for 2027 to be $38,046,656,471, with the lowest CHE revenue forecast at $36,622,030,722, and the highest CHE revenue forecast at $39,680,401,596.
In 2028, CHE is forecast to generate $40,281,619,802 in revenue, with the lowest revenue forecast at $39,092,253,351 and the highest revenue forecast at $41,876,155,044.